Mankind Pharma, the maker of Manforce brand condoms and pregnancy test kits, rallied 32% on its debut on the Indian stock exchange, setting the stage for other IPO hopefuls in an otherwise muted public market this year.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
